SCHEMBL18633827

SCHEMBL18633827

CC(C)(O)c1ccc2c(c1)/C(=C/CCN1CCCC1)C1=CC=CNC1CO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.39
▸ HRH1 P35367 3/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.32
▸ SIGMAR1 Q99720 2/20 0.30
▸ KCNK2 O95069 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ THPO P40225 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ GMNN O75496 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ PMP22 Q01453 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824505 0.91 CCR1 (0.32) CCR1HRH1
SCHEMBL18895930 0.87 CCR1 (0.43) CCR1HRH1SIGMAR1MEN1KMT2A
SCHEMBL15478420 0.86 CCR1 (0.37) CCR1HRH1
SCHEMBL14420192 0.86 CCR1 (0.32) CCR1
SCHEMBL15478375 0.86 CCR1 (0.50) CCR1HRH1HRH3SIGMAR1USP2
SCHEMBL15478377 0.85 CCR1 (0.39) CCR1HRH1TP53LMNA
SCHEMBL12121700 0.85 CYP19A1 (0.31) —
SCHEMBL14420045 0.83 CCR1 (0.40) CCR1MAPK1
SCHEMBL13824459 0.82 CCR1 (0.40) CCR1TP53MEN1KMT2A
SCHEMBL18896010 0.82 CCR1 (0.39) CCR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
EP-1688418-B1 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARM INC (US) 2017-03-15 — — EP disclosed
Send feedback